Chemcrux Enterprises Ltd. engages in the manufacture of intermediates for bulk drugs, dyes, electro-plating, pharmaceuticals, and pigments. The company is headquartered in Ankleshwar, Gujarat. The company went IPO on 2017-03-28. The firm is engaged in manufacturing intermediates for bulk drugs, and dyes and pigments. The firm's products include 2 Chloro Benzoic Acid, 3 Chloro Benzoic Acid, 4 Chloro Benzoic Acid, 2,4 Dichloro Benzoic Acid, 4 Chloro 3 Nitro Benzoic Acid; 2 Chloro 5 Nitro Benzoic Acid; Meta Nitro Benzoic Acid; Lassamide, and Meta Chloro Per Benzoic Acid. The firm also offers various products on custom requirements, including Aceturic Acid; Meta Chloro Benzoyl Chloride; 3-Nitro-4-Methoxy Benzoic Acid; 2 Amino 5 Sulfonamide Benzoic Acid; 3,4 Dichloro Benzoic Acid; 5-Nitro Salycylic Acid, and 4-Chloro Benzoic Acid -3-Sulfonamide. The company is engaged in development and execution of various processes, such as High-Pressure Oxidation, Nitration, Amidation and Chloro Sulfonation.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.
13 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.